key: cord-0920798-3l58xdd5 authors: Li, Wei; Su, Ying-Ying; Zhi, Shen-Shen; Huang, Jian; Zhuang, Chun-Lan; Bai, Wei-Zhi; Wan, Yan; Meng, Xiao-Rong; Zhang, Lu; Zhou, Ying-Bing; Luo, Yu-Yao; Ge, Sheng-Xiang; Chen, Yao-Kai; Ma, Yu title: Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 date: 2020-07-09 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2020.07.008 sha: a011d36441692d473590fd21a05de55cfb967e6c doc_id: 920798 cord_uid: 3l58xdd5 OBJECTIVES: Asymptomatic patients, together with those with mild symptoms of COVID-19, may play an important role in SARS-CoV-2 transmission. However, the dynamics of viral shedding during the various phases of the clinical course of COVID-19 remains unclear at this stage. METHODS: A total of 18 patients found positive for SARS-CoV-2 infection by real-time reverse transcription PCR (RT-PCR) assay, and admitted to Chongqing University Central Hospital between Jan 29 and Feb 5 were enrolled in this study. Medical data, pulmonary CT scan images, and RT-PCR results were periodically collected during the patients’ hospital stay. All participants were actively followed-up for 2 weeks after discharge. RESULTS: A total of nine (50%) asymptomatic patients and nine 9 (50%) mildly mild symptom COVID-19 patients were identified on admission. Six (66.7%) asymptomatic patients on admission developed subjective symptoms during hospitalization were recategorized as ‘pre-symptomatic’. The median duration of viral shedding was 11.5, 28 and 31 days for pre-symptomatic, asymptomatic and mild symptomatic patients, separately. Seven (38.9%) patients continued to shed virus after hospital discharge. During the convalescent phase, detectable antibodies to SARS-CoV-2 and RNA were simultaneously observed in five (27.8%) patients. CONCLUSIONS: Long-term viral shedding was presented in patients with mild symptoms and asymptomatic cases, and specific antibody production to SARS-CoV-2 may not guarantee viral clearance after discharge. These observations should be considered when making decisions regarding clinical and public health and strategies for prevention and control of SARS-CoV-2 infection. Plasma samples were collected and tested for total antibody against SARS-CoV-2 120 with a commercial chemiluminescence microparticle immunoassay (CMIA, Xiamen 121 InnoDx Biotech Co., Ltd., China), which was based on the double-antigen sandwich 122 method as previously described [7] . In this immunoassay, mammalian cell-expressed 123 SARS-CoV-2 spike receptor binding domain (RBD) proteins were utilized as antigens. The assay was performed with an automatic CMIA analyzer Caris200 (Xiamen UMIC The mean CD4+/CD8+ ratio of inpatients, whose RT-PCR remained negative after 197 discharge, was higher than that of those who subsequently developed positive results 198 after discharge (2.0±0.8 vs 1.3±0.6, p=0.09). No statistically significant differences 199 were found between other clinical indices in these two groups. This is likely related to In this study, we observed that long-term intermittent virus shedding was occurred in 213 the respiratory tract of some patients with mild symptoms and asymptomatic cases. During the convalescent phase, detectable antibodies to SARS-CoV-2 and RNA were 215 simultaneously observed in five patients, which suggests that the production of 216 specific antibodies to SARS-CoV-2 may not guarantee viral clearance after discharge. The median duration of viral shedding in our cohort was 23.5 days (range, 3-47days), The authors declare no potential conflicts of interest. line represents hospital discharge. " " throat swab, " " naso-pharyngeal, " " nasal swab, " " sputum, " " anal swab Novel Coronavirus Pneumonia Emergency Response Epidemiology T. The 304 epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases 305 (COVID-19) in China Characteristics of and Important Lessons From the 307 COVID-19) Outbreak in China: Summary of a Report of 308 72 314 Cases From the Chinese Center for Disease Control and Prevention Clinical Characteristics of Coronavirus Disease 311 2019 in China Clinical course and risk factors for mortality of adult 313 inpatients with COVID-19 in Wuhan, China: a retrospective cohort study SARS-CoV-2 Viral Load in Upper Respiratory 316 Specimens of Infected Patients National Health Commission of China New coronavirus pneumonia prevention 318 and control program les/b218cfeb1bc54639af227f922bf6b817.pdf (Access date Antibody responses to SARS-CoV-2 in patients of 322 novel coronavirus disease 2019 Epidemiologic Features and Clinical 324 Course of Patients Infected With SARS-CoV-2 in Singapore Clinical characteristics of 24 asymptomatic infections 326 with COVID-19 screened among close contacts in Nanjing, China. Science China 327 Life Sciences Positive RT-PCR Test Results in Patients Recovered 329 From COVID-19 Syndrome Coronavirus Infection Dynamics and Antibody Responses among 332 Clinically Diverse Patients, Saudi Arabia Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus 335 Infection Heart rate Diastolic blood pressure 121 CD4+(median, IQR) CD8+(median, IQR) CD4+/CD8+(mean, SD) 295 We thank all participants in the study.